Kenya’s Health Director General, Patrick Amoth, has assured the public that the country is well-prepared to manage the recent freeze on U.S.-funded HIV medications, a consequence of executive orders issued by former U.S. President Donald Trump. These orders, particularly those affecting health programs, have raised concerns about disruptions to Kenya’s ongoing HIV/AIDS programs, which have seen significant progress in recent years.
Amoth emphasized that Kenya has sufficient stocks of HIV commodities, including antiretroviral drugs, thanks to strengthened supply chains over the past two years. He confirmed that Kenya currently has more than six months’ worth of stocks to ensure uninterrupted treatment for people living with HIV.
“Our health systems are well-stocked, and we are committed to ensuring that the quality of HIV care continues without compromise,” Amoth stated during a media briefing. He assured that the country’s proactive measures would prevent any shortages despite the global uncertainty caused by the U.S. decision to halt funding.
Over the years, Kenya has made significant strides in its fight against HIV/AIDS, largely aided by international support such as the President’s Emergency Plan for AIDS Relief (PEPFAR). Out of the 1.3 million people living with HIV in Kenya, nearly 98% are aware of their status, with 94% of those receiving treatment achieving viral suppression. These statistics align with the global 95:95:95 targets, which aim to ensure that 95% of people with HIV know their status, 95% are receiving treatment, and 95% of those on treatment are virally suppressed.
However, Amoth warned that the freeze on U.S. HIV funding, combined with the suspension of technical assistance, could jeopardize these advancements, particularly in terms of preventing drug resistance and reducing mother-to-child transmission. The country has made notable progress in reducing mother-to-child transmission of HIV from 15% a decade ago to 7.1% today, a promising trend that could be threatened by funding cuts.
In response, Kenya is working with development partners, international agencies, and the private sector to secure alternative resources and fill any gaps in the supply of essential medications. This collaborative effort is vital for ensuring the continuity of treatment and health services for those most in need.
As Kenya faces the challenge of maintaining its HIV treatment programs amidst a global funding freeze, Amoth stressed the importance of solidarity within the international community to safeguard health financing and prevent setbacks in the fight against HIV/AIDS.
